Every 424B that Xos Inc (XOS) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 424B covers the supplement that carries the terms of a priced offering, so if you follow XOS and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full XOS filings page.
Xos, Inc. is offering shares of its common stock having an aggregate offering price of up to $8,779,902 through an at-the-market program with Roth Capital Partners acting as sales agent, pursuant to a Sales Agreement dated June 22, 2026.
The Sales Agreement permits sales from time to time; Roth Capital Partners will receive 3.0% of gross proceeds as compensation. Proceeds are intended for working capital, debt servicing and general corporate purposes and sales are subject to General Instruction I.B.6 to Form S-3 limiting primary offerings to one-third of public float while below $75,000,000. Shares outstanding were 13,718,819 as of June 17, 2026; an illustrative scenario assumes issuance of 2,593,767 shares at $3.385 per share for the full permitted amount.
Xos, Inc. files a prospectus supplement updating its at-the-market sales capacity under a Sales Agreement with Roth Capital Partners to up to $8,618,796 of common stock. The supplement cites a public float of $59,957,184 based on 8,037,156 shares outstanding as of June 5, 2026 and a prior 12-month issuance of $11,366,932 under the same Form S-3 instruction. The Sales Agreement pays Roth Capital Partners a 3.0% fee on aggregate gross proceeds. The prospectus supplement modifies the ATM Prospectus Supplement and Base Prospectus and is qualified by them.
Xos, Inc. is offering 1,090,910 shares of its common stock at an offering price of $5.50 per share pursuant to this prospectus supplement. The offering's aggregate public offering price is $6,000,005 with placement agent fees of $390,000 (6.5%). After placement agent fees and estimated offering expenses, estimated net proceeds to Xos are approximately $5.4 million. The prospectus states the offering will be conducted on a reasonable "best efforts" basis through Roth Capital Partners, LLC as exclusive placement agent and notes Nasdaq listing under the symbol XOS. Shares outstanding were 12,567,531 as of June 3, 2026 and are projected to be 13,658,441 after this Offering.